Australia regulator approves Pfizer/BioNTech Covid-19 vaccine for use
[SYDNEY] Australia's therapeutic goods regulator has conditionally approved the Pfizer/BioNTech Covid-19 vaccine for use after determining that it met strict standards for safety, quality and efficacy, the federal government said on Monday.
The Therapeutic Goods Administration's (TGA) provisional approval is for people aged over 16, and a priority group of Australians would receive their first of two doses of the vaccine once received from the drugmaker, the government added.
"I welcome the TGA's approval of the Pfizer vaccine, with our own Australian experts finding it is safe, effective and of a high standard," Prime Minister Scott Morrison said in a statement.
REUTERS
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Bankers lose hope of London IPO revival for another year
Decarbonisation schemes are generating hot air
BOJ will hike rates if trend inflation accelerates, says Ueda
India tells spice makers to give details of quality checks after Hong Kong allegations
Eurozone business in services-led bounce in April, PMI survey shows
China’s surging steel exports are inflaming global trade tension